Helix and Nebraska Medicine Partner on Population Genomics Program for Precision Care
The population genomics program will identify participants’ risk for cancer and other life-threatening diseases with a single test.
Read MorePosted by Andy Lundin | Aug 15, 2023 | Cancer |
The population genomics program will identify participants’ risk for cancer and other life-threatening diseases with a single test.
Read MorePosted by Chris Wolski | Aug 7, 2023 | Diabetes & Metabolic Diseases |
While A1c is the diagnostic gold standard for determining if a patient has diabetes, there are a variety of tests that provide flexibility.
Read MorePosted by Andy Lundin | Aug 3, 2023 | Coagulation Testing |
HemoSonics announced its Quantra Hemostasis System received an Innovative Technology contract award from Vizient.
Read MorePosted by Andy Lundin | Aug 3, 2023 | Respiratory Disease |
Cue’s new test would differentiate between influenza A/B, RSV, and COVID simultaneously, with results delivered in approximately 25 minutes.
Read MorePosted by Andy Lundin | Aug 2, 2023 | Covid 19 |
Scientists developed a breath test that quickly identifies those who are infected with the virus that causes COVID.
Read More